Steve Cohen’s billion-dollar spending spree hits a wall as underperforming stars and injury woes leave New York’s ...

At a recent industry event, the 14th Annual Bioprocessing Summit in Boston, scientists discussed a variety of advances in gene therapy manufacturing. To learn more about these advances, GEN talked ...

As the Colorado Avalanche prepare to reload following a disappointing playoff exit, franchise star Cale Makar's contract ...

To design safe clinical trials, it is crucial to better understand and predict gene editing outcomes in preclinical studies. Bence György and collaborators have shown that adeno-associated viruses ...

Several quality attributes (QAs) must be monitored to ensure an effective and safe final product when developing adeno-associated virus (AAV) vectors as drug products. Thermal stability, aggregate ...

In recent years, adeno-associated virus (AAV) has been recognized as the leading vehicle (vector) for in vivo delivery of therapeutic genes because it is non-pathogenic and efficiently targets many ...

Patients with AAV are associated with an increased risk for severe infection compared with members of the general population.

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

The Devils got their most important piece of offseason business done, agreeing to a new contract with Nico Hischier ...